ARGENX SE-ADR - 48 Year Dividend History | ARGX

Historical dividend payout and yield for ARGENX SE-ADR (ARGX) since 1971. The current TTM dividend payout for ARGENX SE-ADR (ARGX) as of April 18, 2019 is $0.00. The current dividend yield for ARGENX SE-ADR as of April 18, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.806B $0.025B
argenx SE is a biopharmaceutical company. It focuses on developing antibody-based therapies for the treatment of autoimmune diseases and cancer. The company's product pipeline consists of ARGX-113, ARGX-110 and ARGX-111 which are in clinical trials. argenx SE is based in Breda, the Netherlands.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $109.312B 12.32
Gilead Sciences (GILD) United States $80.293B 10.22
Bio-Techne Corp (TECH) United States $7.144B 48.13